SFR1
geneOn this page
Also known as MEI5bA373N18.1FLJ41960
Summary
SFR1 (SWI5 dependent homologous recombination repair protein 1, HGNC:29574) is a protein-coding gene on chromosome 10q25.1, encoding Swi5-dependent recombination DNA repair protein 1 homolog (Q86XK3). Component of the SWI5-SFR1 complex, a complex required for double-strand break repair via homologous recombination.
Enables transcription coactivator activity. Involved in cellular response to estrogen stimulus; double-strand break repair via homologous recombination; and positive regulation of DNA-templated transcription. Located in centrosome; nucleolus; and nucleoplasm. Part of Swi5-Sfr1 complex.
Source: NCBI Gene 119392 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_001002759
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29574 |
| Approved symbol | SFR1 |
| Name | SWI5 dependent homologous recombination repair protein 1 |
| Location | 10q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MEI5, bA373N18.1, FLJ41960 |
| Ensembl gene | ENSG00000156384 |
| Ensembl biotype | protein_coding |
| OMIM | 616527 |
| Entrez | 119392 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000369727, ENST00000369729, ENST00000463224
RefSeq mRNA: 4 — MANE Select: NM_001002759
NM_001002759, NM_001384829, NM_001384830, NM_145247
CCDS: CCDS31279, CCDS31280
Canonical transcript exons
ENST00000369727 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001026104 | 104123714 | 104124124 |
| ENSE00001450732 | 104122171 | 104122196 |
| ENSE00003562919 | 104122965 | 104123086 |
| ENSE00003910651 | 104125513 | 104126383 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 94.81.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.3366 / max 324.7888, expressed in 1730 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106867 | 3.2699 | 1257 |
| 106866 | 2.0445 | 1133 |
| 106865 | 1.5162 | 897 |
| 106861 | 0.4706 | 199 |
| 106862 | 0.4454 | 73 |
| 106858 | 0.1436 | 28 |
| 106860 | 0.1419 | 59 |
| 106864 | 0.0942 | 27 |
| 106868 | 0.0878 | 20 |
| 106863 | 0.0650 | 20 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| epithelial cell of pancreas | CL:0000083 | 94.81 | gold quality |
| pancreatic ductal cell | CL:0002079 | 94.59 | gold quality |
| secondary oocyte | CL:0000655 | 94.13 | gold quality |
| oocyte | CL:0000023 | 90.91 | gold quality |
| cartilage tissue | UBERON:0002418 | 90.12 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.06 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 88.76 | gold quality |
| amniotic fluid | UBERON:0000173 | 88.24 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.78 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 85.60 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.47 | gold quality |
| gingival epithelium | UBERON:0001949 | 85.20 | gold quality |
| buccal mucosa cell | CL:0002336 | 85.02 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 84.94 | gold quality |
| parietal pleura | UBERON:0002400 | 84.74 | gold quality |
| tibia | UBERON:0000979 | 84.53 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.30 | gold quality |
| visceral pleura | UBERON:0002401 | 84.30 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 83.79 | gold quality |
| gingiva | UBERON:0001828 | 83.59 | gold quality |
| right testis | UBERON:0004534 | 83.51 | gold quality |
| testis | UBERON:0000473 | 83.00 | gold quality |
| bone marrow | UBERON:0002371 | 82.97 | gold quality |
| left testis | UBERON:0004533 | 82.52 | gold quality |
| monocyte | CL:0000576 | 82.48 | gold quality |
| leukocyte | CL:0000738 | 82.34 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 81.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 81.84 | gold quality |
| corpus epididymis | UBERON:0004359 | 81.62 | gold quality |
| cauda epididymis | UBERON:0004360 | 81.36 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.40 |
| E-GEOD-109979 | no | 58.03 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
52 targeting SFR1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-4520-2-3P | 99.14 | 69.28 | 1009 |
Literature-anchored findings (GeneRIF, showing 2)
- that human SWI5-MEI5 has an evolutionarily conserved function in homologous recombination repair. (PMID:21252223)
- SFR1 is a novel transcriptional modulator for ERalpha and a potential target in breast cancer therapy. (PMID:23874500)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sfr1 | ENSDARG00000021974 |
| mus_musculus | Sfr1 | ENSMUSG00000025066 |
| rattus_norvegicus | Sfr1 | ENSRNOG00000012641 |
Protein
Protein identifiers
Swi5-dependent recombination DNA repair protein 1 homolog — Q86XK3 (reviewed: Q86XK3)
Alternative names: Meiosis protein 5 homolog
All UniProt accessions (1): Q86XK3
UniProt curated annotations — full annotation on UniProt →
Function. Component of the SWI5-SFR1 complex, a complex required for double-strand break repair via homologous recombination. Acts as a transcriptional modulator for ESR1.
Subunit / interactions. Component of the SWI5-SFR1 complex. Interacts with RAD51; the interaction is weak. Interacts with ESR1 in the ligand-independent and ligand-dependent manner.
Subcellular location. Nucleus.
Tissue specificity. Widely expressed.
Similarity. Belongs to the SFR1/MEI5 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86XK3-1 | 1 | yes |
| Q86XK3-2 | 2 | |
| Q86XK3-3 | 3 |
RefSeq proteins (4): NP_001002759, NP_001371758, NP_001371759, NP_660290 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018468 | SFR1/Mei5 | Family |
| IPR042429 | SFR1 | Family |
Pfam: PF10376
UniProt features (10 total): modified residue 3, splice variant 2, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86XK3-F1 | 67.85 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 61, 64, 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 158 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_ORGANELLE_FISSION, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, RIGGI_EWING_SARCOMA_PROGENITOR_DN, GOBP_RESPONSE_TO_ESTROGEN, GOBP_DNA_DAMAGE_RESPONSE, TGANTCA_AP1_C, GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN, GOBP_RESPONSE_TO_HORMONE, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, FISCHER_DREAM_TARGETS, GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION
GO Biological Process (5): double-strand break repair via homologous recombination (GO:0000724), positive regulation of DNA-templated transcription (GO:0045893), cellular response to estrogen stimulus (GO:0071391), DNA repair (GO:0006281), DNA damage response (GO:0006974)
GO Molecular Function (2): transcription coactivator activity (GO:0003713), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), centrosome (GO:0005813), Swi5-Sfr1 complex (GO:0032798)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nuclear lumen | 2 |
| recombinational repair | 1 |
| double-strand break repair | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| cellular response to hormone stimulus | 1 |
| response to estrogen | 1 |
| DNA metabolic process | 1 |
| DNA damage response | 1 |
| cellular response to stress | 1 |
| transcription coregulator activity | 1 |
| positive regulation of DNA-templated transcription | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| nuclear chromosome | 1 |
| chromatin | 1 |
| DNA recombinase mediator complex | 1 |
| nuclear protein-containing complex | 1 |
Protein interactions and networks
STRING
276 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SFR1 | SWI5 | Q1ZZU3 | 997 |
| SFR1 | RAD51 | Q06609 | 726 |
| SFR1 | MND1 | Q9BWT6 | 602 |
| SFR1 | RAD54B | Q9Y620 | 527 |
| SFR1 | SPO11 | Q9Y5K1 | 509 |
| SFR1 | RAD52 | P43351 | 507 |
| SFR1 | MEIOB | Q8N635 | 497 |
| SFR1 | LSM6 | P62312 | 434 |
| SFR1 | ATRX | P46100 | 402 |
| SFR1 | SFI1 | A8K8P3 | 378 |
| SFR1 | FBH1 | Q8NFZ0 | 370 |
| SFR1 | DNAJA3 | Q96EY1 | 359 |
| SFR1 | RAD51AP1 | Q96B01 | 357 |
| SFR1 | POC5 | Q8NA72 | 352 |
| SFR1 | SKIC8 | Q9GZS3 | 329 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SWI5 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| SFR1 | SWI5 | psi-mi:“MI:0915”(physical association) | 0.700 |
| SWI5 | SFR1 | psi-mi:“MI:0407”(direct interaction) | 0.700 |
| SFR1 | SWI5 | psi-mi:“MI:0407”(direct interaction) | 0.700 |
| RNF40 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| RINT1 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TFIP11 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SFR1 | RNF40 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SFR1 | RINT1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SFR1 | TFIP11 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NDC80 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NMI | SFR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HMBOX1 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP70 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRFAP1L1 | SFR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SFR1 | HMBOX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SFR1 | MRFAP1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SFR1 | NDC80 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (68): SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Two-hybrid), SFR1 (Co-fractionation), SFR1 (Biochemical Activity), SFR1 (Two-hybrid), SFR1 (Affinity Capture-Western), ESR1 (Affinity Capture-Western), RNASE7 (Affinity Capture-MS), RBP1 (Affinity Capture-MS)
ESM2 similar proteins: A2BDB7, A2CE83, B2ZX90, D3IUT5, E1BXS0, F4IDY7, P0DPK0, P49069, P58501, Q07532, Q0P4A6, Q1JQE2, Q28GJ0, Q28GL6, Q2KJD6, Q2MJV9, Q2TBJ0, Q2WG79, Q2WG80, Q5F3D1, Q5R789, Q5TID7, Q5U3I2, Q5ZHQ6, Q640U0, Q641E3, Q66H73, Q67W65, Q68F53, Q6AYN9, Q6DRL4, Q6NZY4, Q7TPE5, Q7Z2Z1, Q7ZX27, Q80YR7, Q80ZU5, Q86XK3, Q8BQ33, Q8C6C7
Diamond homologs: B7ZD04, E1BXS0, Q68F53, Q6TXG9, Q86XK3, Q8BP27
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
549 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:104123087:G:GG | donor_gain | 1.0000 |
| 10:104123125:GTTTC:G | donor_gain | 1.0000 |
| 10:104123126:TTTCT:T | donor_gain | 1.0000 |
| 10:104123777:AATGT:A | acceptor_gain | 1.0000 |
| 10:104122266:T:G | donor_gain | 0.9900 |
| 10:104123129:C:CG | donor_gain | 0.9900 |
| 10:104123129:C:G | donor_gain | 0.9900 |
| 10:104123777:A:AG | acceptor_gain | 0.9900 |
| 10:104124120:CAAAG:C | donor_loss | 0.9900 |
| 10:104124121:AAAG:A | donor_loss | 0.9900 |
| 10:104124122:AAGG:A | donor_loss | 0.9900 |
| 10:104124123:AGGTG:A | donor_loss | 0.9900 |
| 10:104124124:GG:G | donor_loss | 0.9900 |
| 10:104124125:GT:G | donor_loss | 0.9900 |
| 10:104124126:T:A | donor_loss | 0.9900 |
| 10:104125510:CA:C | acceptor_loss | 0.9900 |
| 10:104125511:A:AG | acceptor_gain | 0.9900 |
| 10:104125511:AG:A | acceptor_loss | 0.9900 |
| 10:104125511:AGAAT:A | acceptor_gain | 0.9900 |
| 10:104125512:G:GG | acceptor_gain | 0.9900 |
| 10:104125512:GA:G | acceptor_gain | 0.9900 |
| 10:104125512:GAAT:G | acceptor_gain | 0.9900 |
| 10:104125512:GAATG:G | acceptor_gain | 0.9900 |
| 10:104122194:G:T | donor_gain | 0.9800 |
| 10:104125506:GTTTC:G | acceptor_loss | 0.9800 |
| 10:104125512:GAA:G | acceptor_gain | 0.9800 |
| 10:104122245:G:GT | donor_gain | 0.9700 |
| 10:104122964:GAGAA:G | acceptor_gain | 0.9700 |
| 10:104123039:GCCTC:G | donor_gain | 0.9700 |
| 10:104123777:AAT:A | acceptor_gain | 0.9700 |
AlphaMissense
1623 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:104125549:T:A | W195R | 0.998 |
| 10:104125549:T:C | W195R | 0.998 |
| 10:104124096:T:C | L173P | 0.995 |
| 10:104125551:G:C | W195C | 0.994 |
| 10:104125551:G:T | W195C | 0.994 |
| 10:104125561:A:C | S199R | 0.994 |
| 10:104125563:C:A | S199R | 0.994 |
| 10:104125563:C:G | S199R | 0.994 |
| 10:104124102:T:C | L175P | 0.991 |
| 10:104125691:T:C | F242S | 0.991 |
| 10:104125669:T:G | Y235D | 0.989 |
| 10:104125690:T:C | F242L | 0.989 |
| 10:104125692:T:A | F242L | 0.989 |
| 10:104125692:T:G | F242L | 0.989 |
| 10:104124090:G:C | R171P | 0.987 |
| 10:104125631:T:C | L222S | 0.986 |
| 10:104124124:G:C | K182N | 0.984 |
| 10:104124124:G:T | K182N | 0.984 |
| 10:104125550:G:C | W195S | 0.984 |
| 10:104123742:T:C | L55S | 0.982 |
| 10:104124087:T:C | L170P | 0.982 |
| 10:104124113:T:G | Y179D | 0.981 |
| 10:104124118:A:C | R180S | 0.981 |
| 10:104124118:A:T | R180S | 0.981 |
| 10:104125529:T:C | L188S | 0.981 |
| 10:104125574:T:A | L203H | 0.981 |
| 10:104125664:T:A | L233Q | 0.981 |
| 10:104125574:T:C | L203P | 0.980 |
| 10:104125574:T:G | L203R | 0.980 |
| 10:104125670:A:C | Y235S | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000023122 (10:104123326 T>A), RS1000545141 (10:104119060 C>T), RS1000593197 (10:104121875 C>A,T), RS1001548800 (10:104120849 T>G), RS1001936710 (10:104122303 C>G,T), RS1002526970 (10:104121983 G>A), RS1002557887 (10:104121771 G>A), RS1002655277 (10:104119714 T>C), RS1002955706 (10:104124714 G>A), RS1003532453 (10:104122883 A>G), RS1003553853 (10:104123266 C>T), RS1003563199 (10:104122597 G>A,C), RS1003925160 (10:104120579 A>C,G), RS1004012639 (10:104123580 T>G), RS1004277297 (10:104120157 A>G)
Disease associations
OMIM: gene MIM:616527 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001949_12 | Preeclampsia | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| Cyclosporine | affects expression, increases expression | 3 |
| bisphenol S | decreases methylation, increases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | increases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cisplatin | increases expression | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Thimerosal | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
5 cell lines: 5 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TK82 | HAP1 SFR1 (-) 1 | Cancer cell line | Male |
| CVCL_XS64 | HAP1 SFR1 (-) 2 | Cancer cell line | Male |
| CVCL_XS65 | HAP1 SFR1 (-) 3 | Cancer cell line | Male |
| CVCL_XS66 | HAP1 SFR1 (-) 4 | Cancer cell line | Male |
| CVCL_XS67 | HAP1 SFR1 (-) 5 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): preeclampsia